
NEW BRUNSWICK, N.J. Johnson & Johnson is earmarking nearly $9 billion to cover accusations that its baby power containing talc caused cancer — more than quadrupling the amount the company previously set aside to pay for its potential liability.
A J&J subsidiary plans to re-file for Chapter 11 bankruptcy protection and seek court approval for a plan that would result in one of the largest product-liability settlements in U.S. history.